RU
HIV/AIDS
Etravirine PSK
Registration certificate:
LP-№(001452)-(RG-RU)
INN:
Etravirine
Release form:
Tablets
Therapeutic Area:
HIV/AIDS
Pharmacotherapeutic Group:
Antiviral agents for systemic use, Direct-acting antivirals, Non-nucleoside reverse transcriptase inhibitors
Conditions for dispensing:
On prescription
Packaging:

Indications for Use:

  • This medication is intended for oral use and is indicated for the treatment of HIV-1 infection in adults and children aged 2 years and older (weighing more than 30 kg) who have previously received antiretroviral therapy.

This product is included in the Essential Medicines List (EML).

Quality control
at all stages of production